Advertisement

Picture Flex CTMS with Built-in eTMF LSE 650x100px
Organisation › Details

Genovis AB

Genovis’ business concept is to apply its knowledge and imagination to design and provide innovative tools for development of the drugs of the future. Today Genovis sells several enzyme products known as SmartEnzymes™ all over the world in innovative product formats that facilitate development and quality control of biological drugs. The Group consists of Genovis AB and the wholly owned subsidiary Genovis Inc. (US). Genovis’ shares are listed on NASDAQ First North Stockholm and Erik Penser Bank is the Company’s Certified Adviser *

 

Period Start 2009-01-22 existent
  Group Genovis (Group)
     
Region Region Lund
  Country Sweden
  Street 2 Scheelevägen
Medicon Village
  City 22007 Lund
  Tel +46-46-101230
    Address record changed: 2024-01-05
     
Basic data Employees B: 11 to 50 (2025-12-31)
  Currency SEK
  Annual sales 128,946,000 (net sales, consolidated (2025) 2025-12-31)
  Profit 23,498,000 (2025-12-31)
  Cash 163,192,000 (2025-12-31)
     
    * Document for »About Section«: 
     
   
Record changed: 2026-10-05

Advertisement

Picture Flex Databases Software for Life Sciences LSE 650x200px

More documents for Genovis (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group BIO-Europe 2026 Köln Cologne to 23 Oct 650x200px




» top